KALA BIO
KALA
25 hedge funds and large institutions have $23.7M invested in KALA BIO in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 7 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
1% less capital invested
Capital invested by funds: $24M → $23.7M (-$285K)
4% less funds holding
Funds holding: 26 → 25 (-1)
7.06% less ownership
Funds ownership: 75.06% → 68% (-7.1%)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$2.1M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$1.96M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$751K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$595K |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$568K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$944K |
| 2 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$147K |
| 3 |
Two Sigma Investments
New York
|
-$82.4K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$60.9K |
| 5 |
Citigroup
New York
|
-$39.4K |
KALA Hedge Fund Activity: Q1 2025 in Review
25 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2025, worth a combined $23.7M — down 1.2% from $24M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of KALA and 6 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 7 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $2.1M. The largest seller was Millennium Management, exiting entirely with an estimated $944K sold.
- 25 institutional investors held KALA BIO (KALA) as of Q1 2025, down from 26 in Q4 2024.
- Funds reported $23.7M of KALA BIO stock for Q1 2025, down 1.2% quarter-over-quarter.
- 6 funds opened new KALA BIO positions in Q1 2025 and 7 closed out, a net change of -1 holder.
- The largest KALA BIO buyer in Q1 2025 was Perceptive Advisors, an estimated $2.1M added.
- The largest KALA BIO seller in Q1 2025 was Millennium Management, an estimated $944K sold.
Based on aggregated 13F filings for Q1 2025.